STOCK TITAN

[SCHEDULE 13D/A] Advanced Flower Capital Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A
Rhea-AI Filing Summary

Amendment No. 2 to a Schedule 13D reports that Leonard M. Tannenbaum beneficially owns 6,241,981 shares of Advanced Flower Capital Inc., representing 27.6% of the 22,594,541 shares outstanding as of August 13, 2025. The filing states Mr. Tannenbaum acquired additional Common Stock in multiple open market purchases since his prior Schedule 13D/A on July 2, 2024, using personal funds; those transactions are said to be listed on Schedule A. His holdings include 4,148,243 shares held directly, 186,780 shares of restricted stock and 1,906,958 shares issuable upon exercise of options exercisable within 60 days. The filing disclaims beneficial ownership of 180,400 shares held by the Tannenbaum Family Foundation and 211,827 shares held by his spouse.

Emendamento n. 2 al Schedule 13D segnala che Leonard M. Tannenbaum detiene beneficiariamente 6.241.981 azioni di Advanced Flower Capital Inc., corrispondenti al 27,6% delle 22.594.541 azioni in circolazione al 13 agosto 2025. La comunicazione indica che il sig. Tannenbaum ha acquisito ulteriori azioni ordinarie in più acquisti sul mercato aperto dal suo precedente Schedule 13D/A del 2 luglio 2024, impiegando fondi personali; tali operazioni sono elencate nell'Allegato A. Le sue partecipazioni includono 4.148.243 azioni detenute direttamente, 186.780 azioni vincolate e 1.906.958 azioni da emettere in seguito all'esercizio di opzioni esercitabili entro 60 giorni. La segnalazione esclude la proprietà beneficiaria di 180.400 azioni detenute dalla Tannenbaum Family Foundation e di 211.827 azioni detenute dal coniuge.

Enmienda n.º 2 al Schedule 13D informa que Leonard M. Tannenbaum posee beneficiariamente 6.241.981 acciones de Advanced Flower Capital Inc., lo que representa el 27,6% de las 22.594.541 acciones en circulación a fecha del 13 de agosto de 2025. El documento indica que el Sr. Tannenbaum adquirió acciones ordinarias adicionales en varias compras en el mercado abierto desde su anterior Schedule 13D/A del 2 de julio de 2024, usando fondos personales; dichas transacciones figuran en el Anexo A. Su tenencia comprende 4.148.243 acciones en propiedad directa, 186.780 acciones restringidas y 1.906.958 acciones a emitir por ejercicio de opciones ejercitables dentro de 60 días. La presentación niega la propiedad beneficiaria de 180.400 acciones en poder de la Tannenbaum Family Foundation y de 211.827 acciones en poder de su cónyuge.

Schedule 13D 수정안 제2호에 따르면 Leonard M. Tannenbaum은 Advanced Flower Capital Inc.의 주식 6,241,981주를 사실상 보유하고 있으며, 이는 2025년 8월 13일 기준 발행주식 22,594,541주의 27.6%에 해당합니다. 신고서에는 Tannenbaum 씨가 2024년 7월 2일자 이전 Schedule 13D/A 이후 개인 자금을 사용해 공개 시장에서 다수의 추가 보통주를 매입했으며, 해당 거래들은 부속서 A에 기재되어 있다고 명시되어 있습니다. 그의 보유 내역은 직접 보유한 4,148,243주, 제한주식 186,780주, 그리고 60일 내에 행사 가능한 옵션으로 인수 가능한 1,906,958주를 포함합니다. 신고서는 Tannenbaum Family Foundation이 보유한 180,400주 및 그의 배우자가 보유한 211,827주에 대해서는 사실상 소유권을 부인합니다.

Avenant n°2 au Schedule 13D indique que Leonard M. Tannenbaum détient en fait 6 241 981 actions d'Advanced Flower Capital Inc., représentant 27,6% des 22 594 541 actions en circulation au 13 août 2025. Le dépôt précise que M. Tannenbaum a acquis des actions ordinaires supplémentaires lors de plusieurs achats sur le marché depuis son précédent Schedule 13D/A du 2 juillet 2024, en utilisant des fonds personnels ; ces opérations sont listées en Annexe A. Ses avoirs comprennent 4 148 243 actions détenues directement, 186 780 actions restreintes et 1 906 958 actions à émettre lors de l'exercice d'options exerçables dans les 60 jours. Le dépôt décline la qualité de propriétaire bénéficiaire pour 180 400 actions détenues par la Tannenbaum Family Foundation et 211 827 actions détenues par son conjoint.

Änderung Nr. 2 zu Schedule 13D berichtet, dass Leonard M. Tannenbaum wirtschaftlich 6.241.981 Aktien der Advanced Flower Capital Inc. besitzt, was 27,6% der 22.594.541 ausstehenden Aktien zum 13. August 2025 entspricht. Die Einreichung gibt an, dass Herr Tannenbaum seit seinem vorherigen Schedule 13D/A vom 2. Juli 2024 weitere Stammaktien durch mehrere Käufe am offenen Markt mit persönlichen Mitteln erworben hat; diese Transaktionen sind in Anlage A aufgeführt. Sein Bestand umfasst 4.148.243 direkt gehaltene Aktien, 186.780 beschränkte Aktien und 1.906.958 Aktien, die bei Ausübung von Optionen innerhalb von 60 Tagen ausgegeben werden können. In der Einreichung wird der wirtschaftliche Besitz von 180.400 Aktien, die von der Tannenbaum Family Foundation gehalten werden, und von 211.827 Aktien, die von seinem Ehepartner gehalten werden, verneint.

Positive
  • Significant accumulation: Reporting person increased holdings via open market purchases, signaling continued insider investment
  • Transparent breakdown: Filing discloses direct shares, restricted stock, and options exercisable within 60 days (totaling 6,241,981 shares)
Negative
  • Concentrated ownership: A 27.6% stake may raise governance and control implications for other shareholders
  • Schedule A not included here: Transaction-level details (dates and amounts) referenced but not provided in the supplied content

Insights

TL;DR: Reporting person holds a large, near-controlling 27.6% stake largely via direct shares and exercisable options.

The disclosed 6.24 million-share position, including nearly 1.91 million options exercisable within 60 days, meaningfully concentrates economic and voting exposure in one individual. The purchases were made with personal funds in open market transactions and were material enough to require amendment. For investors this signals continued insider accumulation and potential influence on corporate strategy or control dynamics; however, no transaction prices, dates, or Schedule A detail are provided here to assess timing or cost basis.

TL;DR: A single holder at 27.6% raises governance and influence considerations for Advanced Flower Capital.

Such a substantial ownership stake can affect board composition, shareholder proposals, and strategic outcomes. The filing appropriately identifies shares excluded from beneficial ownership (foundation and spouse). The amendment reports incremental open-market accumulation but does not include Schedule A detail in the provided text, limiting assessment of whether purchases alter voting dynamics over time.

Emendamento n. 2 al Schedule 13D segnala che Leonard M. Tannenbaum detiene beneficiariamente 6.241.981 azioni di Advanced Flower Capital Inc., corrispondenti al 27,6% delle 22.594.541 azioni in circolazione al 13 agosto 2025. La comunicazione indica che il sig. Tannenbaum ha acquisito ulteriori azioni ordinarie in più acquisti sul mercato aperto dal suo precedente Schedule 13D/A del 2 luglio 2024, impiegando fondi personali; tali operazioni sono elencate nell'Allegato A. Le sue partecipazioni includono 4.148.243 azioni detenute direttamente, 186.780 azioni vincolate e 1.906.958 azioni da emettere in seguito all'esercizio di opzioni esercitabili entro 60 giorni. La segnalazione esclude la proprietà beneficiaria di 180.400 azioni detenute dalla Tannenbaum Family Foundation e di 211.827 azioni detenute dal coniuge.

Enmienda n.º 2 al Schedule 13D informa que Leonard M. Tannenbaum posee beneficiariamente 6.241.981 acciones de Advanced Flower Capital Inc., lo que representa el 27,6% de las 22.594.541 acciones en circulación a fecha del 13 de agosto de 2025. El documento indica que el Sr. Tannenbaum adquirió acciones ordinarias adicionales en varias compras en el mercado abierto desde su anterior Schedule 13D/A del 2 de julio de 2024, usando fondos personales; dichas transacciones figuran en el Anexo A. Su tenencia comprende 4.148.243 acciones en propiedad directa, 186.780 acciones restringidas y 1.906.958 acciones a emitir por ejercicio de opciones ejercitables dentro de 60 días. La presentación niega la propiedad beneficiaria de 180.400 acciones en poder de la Tannenbaum Family Foundation y de 211.827 acciones en poder de su cónyuge.

Schedule 13D 수정안 제2호에 따르면 Leonard M. Tannenbaum은 Advanced Flower Capital Inc.의 주식 6,241,981주를 사실상 보유하고 있으며, 이는 2025년 8월 13일 기준 발행주식 22,594,541주의 27.6%에 해당합니다. 신고서에는 Tannenbaum 씨가 2024년 7월 2일자 이전 Schedule 13D/A 이후 개인 자금을 사용해 공개 시장에서 다수의 추가 보통주를 매입했으며, 해당 거래들은 부속서 A에 기재되어 있다고 명시되어 있습니다. 그의 보유 내역은 직접 보유한 4,148,243주, 제한주식 186,780주, 그리고 60일 내에 행사 가능한 옵션으로 인수 가능한 1,906,958주를 포함합니다. 신고서는 Tannenbaum Family Foundation이 보유한 180,400주 및 그의 배우자가 보유한 211,827주에 대해서는 사실상 소유권을 부인합니다.

Avenant n°2 au Schedule 13D indique que Leonard M. Tannenbaum détient en fait 6 241 981 actions d'Advanced Flower Capital Inc., représentant 27,6% des 22 594 541 actions en circulation au 13 août 2025. Le dépôt précise que M. Tannenbaum a acquis des actions ordinaires supplémentaires lors de plusieurs achats sur le marché depuis son précédent Schedule 13D/A du 2 juillet 2024, en utilisant des fonds personnels ; ces opérations sont listées en Annexe A. Ses avoirs comprennent 4 148 243 actions détenues directement, 186 780 actions restreintes et 1 906 958 actions à émettre lors de l'exercice d'options exerçables dans les 60 jours. Le dépôt décline la qualité de propriétaire bénéficiaire pour 180 400 actions détenues par la Tannenbaum Family Foundation et 211 827 actions détenues par son conjoint.

Änderung Nr. 2 zu Schedule 13D berichtet, dass Leonard M. Tannenbaum wirtschaftlich 6.241.981 Aktien der Advanced Flower Capital Inc. besitzt, was 27,6% der 22.594.541 ausstehenden Aktien zum 13. August 2025 entspricht. Die Einreichung gibt an, dass Herr Tannenbaum seit seinem vorherigen Schedule 13D/A vom 2. Juli 2024 weitere Stammaktien durch mehrere Käufe am offenen Markt mit persönlichen Mitteln erworben hat; diese Transaktionen sind in Anlage A aufgeführt. Sein Bestand umfasst 4.148.243 direkt gehaltene Aktien, 186.780 beschränkte Aktien und 1.906.958 Aktien, die bei Ausübung von Optionen innerhalb von 60 Tagen ausgegeben werden können. In der Einreichung wird der wirtschaftliche Besitz von 180.400 Aktien, die von der Tannenbaum Family Foundation gehalten werden, und von 211.827 Aktien, die von seinem Ehepartner gehalten werden, verneint.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
This Amendment No. 2 to Schedule 13D (this "Amendment No. 2") amends and supplements the Schedule 13D originally filed with the Securities and Exchange Commission (the "SEC") by Leonard M. Tannenbaum (the "Reporting Person") with respect to Advanced Flower Capital Inc. (the "Issuer") on April 2, 2021 (the "Schedule 13D"), as amended by Amendment No. 1 to Schedule 13D filed on July 2, 2024. This Amendment No. 2 is being filed solely to report purchases of Common Stock that in aggregate exceeded 1% of the Issuer's outstanding Common Stock since the Reporting Person's last Schedule 13D/A filing, while the Reporting Person's overall percentage ownership did not increase by more than 1%. The Schedule 13D is hereby amended and supplemented to include the information set forth herein. Capitalized terms not defined herein have the meanings given to such terms in the Schedule 13D. Except as set forth herein, the Schedule 13D is unmodified. Lines 7 and 9 consist of 4,148,243 shares of Common Stock, par value $0.01 per share, of the Issuer (the "Common Stock") held directly by the Reporting Person and 186,780 shares of restricted stock held by the Reporting Person and 1,906,958 shares of Common Stock issuable upon exercise of stock options held directly by the Reporting Person and exercisable within 60 days. Excludes (i) 180,400 shares of Common Stock held by the Tannenbaum Family Foundation (formerly known as the Leonard M. Tannenbaum Foundation), for which the Reporting Person serves as the President, over which the Reporting Person disclaims beneficial ownership, except to the extent of his pecuniary interest and (ii) 211,827 shares of Common Stock (including restricted stock and shares underlying stock options exercisable within 60 days) held by Ms. Robyn Tannenbaum, the Reporting Person's spouse, over which the Reporting Person disclaims beneficial ownership. Line 13 is based on the 22,594,541 shares of Common Stock outstanding as of August 13, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q, filed with the SEC on August 14, 2025.


SCHEDULE 13D


Leonard M. Tannenbaum
Signature:/s/ Leonard M. Tannenbaum
Name/Title:Leonard M. Tannenbaum
Date:08/26/2025
Advanced Flower Capital Inc

NASDAQ:AFCG

AFCG Rankings

AFCG Latest News

AFCG Latest SEC Filings

AFCG Stock Data

95.57M
17.86M
20.04%
30.34%
4.57%
REIT - Mortgage
Real Estate
Link
United States
WEST PALM BEACH